腋窝多汗症诊断及A型肉毒毒素注射治疗专家共识  

Consensus on Axillary Hyperhidrosis Diagnosis and Botulinum Toxin Type A Treatment

作　　者：中国抗衰老促进会皮肤慢病管理与健康促进分会 中国中西医结合学会皮肤科分会医美微创注射治疗学组 李利 李祎铭 Skin Chronic Disease Management and Health Promotion Branch of China Anti-Aging Promotion Association;Medical Minimally Invasive Injection Therapy Group of Dermatology Branch of China Association of Integrated Traditional Chinese and Western Medicine;LI Li

机构地区：[1]不详

出　　处：《中国皮肤性病学杂志》2024年第3期237-242,共6页The Chinese Journal of Dermatovenereology

摘　　要：近年来,A型肉毒毒素治疗腋窝多汗症的应用日益广泛。由于目前国内外尚无统一规范的汗液测量方法,导致临床诊疗和科学研究中存在一定的差异。为了更好地规范腋窝汗液测量方法,提升A型肉毒毒素治疗腋窝多汗症的水平,专家组针对腋窝多汗症的诊断、严重程度分级、A型肉毒毒素治疗的理论依据、流程、补充治疗、治疗间隔、不良反应等问题制订了本共识,为疾病的诊断及治疗提供指导意见。The application of botulinum toxin type A(BTX-A)in axillary hyperhidrosis treatment has become increasingly widespread in recent years.However,the gap between the clinical practice and scientific research remains due to the lack of standardized sweat measuring method.Aiming at standardizing the measurement of axillary sweat and improving the BTX-A treatment for axillary hyperhidrosis,the expert group has developed this consensus on axillary hyperhidrosis diagnosis,severity grading,theoretical basis of BTX-A treatment,injection process,touch-up treatment,treatment interval,and adverse reactions.The consensus may provide guidance for the diagnosis and treatment of the disease.

关 键 词：原发性多汗症 腋窝多汗症 A型肉毒毒素 重量法 碘淀粉试验 多汗症疾病严重程度量表 

分 类 号：R758.74[医药卫生—皮肤病学与性病学]